Anzeige
Mehr »
Donnerstag, 07.08.2025 - Börsentäglich über 12.000 News
Große CEO-Enthüllung: Analysten sehen +56% Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N7N8 | ISIN: KYG4818G1010 | Ticker-Symbol: 6IB
Tradegate
06.08.25 | 21:15
10,600 Euro
-0,93 % -0,100
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
INNOVENT BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
INNOVENT BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
10,00010,30015:44
10,20010,30015:43

Aktuelle News zur INNOVENT BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:17INNOVENT BIO Expects 1H Total Product Rev. RMB5.2B+, Up 35% YoY1
11:30INNOVENT BIO (01801): INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THE SECOND QUARTER OF 20253
DiInnovent Biologics: Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI303260SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
► Artikel lesen
MoINNOVENT BIO (01801): DATE OF BOARD MEETING1
18.07.JPM Favors AKESO/INNOVENT BIO/HENGRUI PHARMA as CN Healthcare Sector Rebounds Sharply This Yr27
17.07.Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma109SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
► Artikel lesen
INNOVENT BIOLOGICS Aktie jetzt für 0€ handeln
08.07.CLSA Raises INNOVENT BIO (01801.HK) TP to HKD108.4; Focus on Next-Gen Oncology Franchise6
08.07.Daiwa Lifts INNOVENT BIOs TP to HKD95, Reiterates Rating Buy5
08.07.CCBI Elevates INNOVENT BIO (01801.HK) TP to $100, Keeps Rating at Outperform3
08.07.HSBC Research Raises INNOVENT BIOs TP to HKD110; Rating Kept Buy3
04.07.INNOVENT BIO (01801): NEXT DAY DISCLOSURE RETURN1
04.07.INNOVENT BIO (01801): COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE1
30.06.INNOVENT BIO (01801): GRANT OF SHARE OPTIONS AND RESTRICTED SHARES2
30.06.Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent gains approval for mazdutide61
27.06.With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs23
27.06.Innovent's Mazdutide receives approval for chronic weight management in China2
27.06.Innovent Biologics' Mazdutide Gets China Approval For Chronic Weight Management435BEIJING (dpa-AFX) - Innovent Biologics, Inc. (IVBXF.OB) announced Friday that China's National Medical Products Administration or NMPA has approved mazdutide for chronic weight management in...
► Artikel lesen
27.06.INNOVENT BIO (01801): VOLUNTARY ANNOUNCEMENT - FIRST DUAL GCG/GLP-1 RECEPTOR AGONIST MAZDUTIDE RECEIVED APPROVAL BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ...2
26.06.INNOVENT BIO (01801): PLACING OF NEW SHARES UNDER GENERAL MANDATE2
25.06.INNOVENT BIO (01801): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 25, 20253
Weiter >>
73 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1